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Chronic abdominal vagus stimulation 
increased brain metabolic connectivity, reduced 
striatal dopamine transporter and increased 
mid-brain serotonin transporter in obese 
miniature pigs
Charles‑Henri Malbert1* , Mickael Genissel2, Jean‑Louis Divoux3 and Christine Henry4
Abstract 
Background/objective: Changes in brain metabolism has been investigated thoroughly during unilateral cervical 
chronic vagal stimulation in epileptic or depressive patients. Bilateral stimulation of the abdominal vagus (aVNS) has 
received less attention despite the reduction in body weight and an altered feeding behavior in obese animals that 
could be clinically relevant in obese individuals. Our study aims to examine the changes in brain glucose metabolism 
 (CMRglu) induced by aVNS in obese adult miniature pigs. Dopamine (DAT) and serotonin transporters (SERT) were also 
quantified to further understand the molecular origins of the alterations in brain metabolism.
Subjects/methods: Pairs of stimulating electrodes were implanted during laparoscopy on both abdominal vagal 
trunks in 20 obese adult’s miniature pigs. Half of the animals were permanently stimulated while the remaining were 
sham stimulated. Two months after the onset of stimulation, dynamic 18FDG PET and 
123I‑ioflupane SPECT were per‑
formed. Food intake, resting energy expenditure and fat deposition were also assessed longitudinally.
Results: Food intake was halved and resting energy expenditure was increased by 60% in aVNS group compared 
to sham. The gain in body weight was also 38% less in aVNS group compared to sham. Brain metabolic connectivity 
increased between numerous structures including striatum, mid‑brain, amygdala and hippocampus. On the contrary, 
increased  CMRglu were restricted to the thalamus, the periaqueducal grey and the amygdala. DAT binding potential 
was decreased by about one third in the striatum while SERT was about doubled in the midbrain.
Conclusions: Our findings demonstrated that aVNS reduced weight gain as a consequence of diminished daily 
food intake and increased resting energy expenditure. These changes were associated with enhanced connectivity 
between several brain areas. A lower striatal DAT together with a doubled mid‑brain SERT were likely causative for 
these changes.
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Background
Obesity and its consequences are a worldwide public 
health issue especially because effective reversible bari-
atric procedures or pharmacological treatments without 
serious adverse-effects are still in infancy [1]. Central 
neuromodulation using vagal stimulation might become 
an alternate therapeutic tool [2] since it increased satia-
tion [3], reduced food intake [2] and increased energy 
expenditure [4] without adverse side effects [5]. Further-
more, it restored insulin sensitivity in obese animals and 
improved the insulin-dependent glucose metabolism 
of several organs including the brain [6]. The maximum 
effectiveness towards weight loss was observed with 
bilateral stimulation performed at the level of the abdom-
inal branches (aVNS) [7]. Therefore, it is significantly 
more complicated than the one used for refractory epi-
lepsy or depression which involve stimulation of the left 
cervical vagus only [8]. However, since it was performed 
below the cardiac branches, it avoids unwanted cardiac 
side effects [5].
While the impact of aVNS on brain function is largely 
unknown, several studies have investigated the effect of 
left cervical VNS on brain function using PET and fMRI 
imaging both in animals and humans. In epileptic or 
depressive patients, cervical VNS induced a gradual brain 
response involving a change in dorsolateral prefrontal/
cingulate cortical activities followed by dopaminergic 
activation of the limbic system [9] or limbic-connected 
structures [10, 11]. A widespread impact involving sev-
eral functional brain networks [12, 13] has been also 
identified. Opposite to those results, the effects observed 
in obese animals, during insulin stimulation, after long-
lasting aVNS were restricted to fewer brain areas involv-
ing the amygdala, the dorsal cingulate cortex and the 
anterior prefrontal cortex [6]. Unfortunately, the different 
experimental conditions make challenging to ascertain 
for significant differences of brain response/metabolism 
during abdominal vs. cervical VNS.
The mesolimbic dopamine reward system plays a 
central role in the regulation of eating behavior [14] 
and dopamine receptors availability was lower in mor-
bidly obese individuals [15]. Conversely, cervical VNS 
increased extracellular striatal dopamine levels [9, 16]. 
Therefore, striatal dopamine changes induced by VNS 
could be pivotal to explain the reduced food intake 
observed during aVNS. Furthermore, in addition to dopa-
mine, the other brain neurotransmission system—sero-
tonin might be altered by vagal stimulation. Serotonin 
transporter (SERT) activity in the dorsal raphe nucleus 
of the dorsal mid-brain has been identified recently as a 
critical player for the control of food intake [17]. Former 
studies have also demonstrated that the activity of SERT 
within the mid-brain was altered by cervical unilateral 
vagal stimulation [18]. Taken together, these data suggest 
that mid-brain SERT in conjunction with striatal DAT 
might be responsible for the  VNSa reduced food intake 
and body weight.
Our study aimed to characterize the effects of pro-
longed bilateral stimulation of the abdominal branches 
of the vagus on brain activity in a large animal model 
of acquired obesity. Since vagal stimulation is likely to 
alter the metabolism of specific brain areas as well as 
the organization of several brain networks [12, 19], the 
analysis of PET 18FDG images will be performed using 
both statistical parametric and network mapping. Fur-
thermore, the binding potential for dopamine (DAT) and 
serotonin (SERT) transporters was investigated using 
quantitative dynamic SPECT imaging after the admin-
istration of 123I-Ioflupane. We perform our experiment 
on Yucatan mini-pigs, a model known to develop obe-
sity in response to high fat/sucrose diet [20], that is bulky 
enough to allow placement of stimulating electrodes 
around the abdominal vagal trunks using laparoscopy [7] 
and with relatively large brain with well-defined cerebral 
gyri [21, 22].
Materials and methods
The experiment was conducted in accordance with 
the current ethical standards of the European legisla-
tion after approval by the Ethics Committee of Rennes 
(R-2011-MO-01).
a. Experimental design and animal model
A total of 20 Yucatan mini-pigs, aged 3 years, were used 
throughout the experiment. Several studies suggested 
that DAT availability was higher in females than in males 
[23]. Therefore, we decided to use only female animals 
in our experiment. The animals were made obese using 
high fat, high sucrose diet (4024 kcal/kg of feed) supplied 
at 150% of the recommended caloric intake (288 kcal/kg 
 BW0.75) [24]. This feeding scheme was maintained during 
the entire experiment.
Once obese, i.e., after 5 months of the obesogenic diet, 
the animals were fitted by laparoscopy with stimulating 
electrodes around the abdominal vagal trunks connected 
to a subcutaneous stimulator (see “b. Vagal stimulation”). 
Ten animals, selected at random, were vagally stimu-
lated while a nonfunctional stimulator was inserted in 
the remaining ten animals. The stimulation was started 
immediately after surgery and continued for 2  months. 
During this period, the food intake and the electrodes/
stimulator impedance were recorded daily. Body weight 
was measured every week. Then 18FDG PET and 123I-iof-
lupane SPECT imaging were performed at least 4  days 
apart. Additional phenotypic characterization of the 
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obesity in both groups was achieved during terminal 
anesthesia.
b. Vagal stimulation
Two sets of cuff electrodes were fixed on the dorsal and 
ventral vagal trunks using laparoscopy as previously 
described [7]. The stimulating electrodes consisted of 
in-cuff electrodes for a nerve diameter target of about 
3.0 mm and comprised two pairs of Pt–Ir 10% half circu-
lar contacts (4 in total), short-circuited together to form 
a bipolar configuration. Pairs of contacts were located 
on both sides of a tube, creating a circumference, 10 mm 
distal from the other pair of contacts. The overall dimen-
sion of the cuff was 25 ± 0.1 mm.
The electrode leads were connected to a neurostimula-
tor that was implanted in a subcutaneous pocket behind 
the last left rib. The neurostimulator was able to deliver 
a current-controlled pulse to the two set of electrodes. 
It included an impedance measuring subroutine that 
allowed the maximum and minimum impedance values 
to be recorded daily. Stimulation was delivered as bipha-
sic squared pulse trains. The frequency of the pulses 
within the train was 30 Hz for a 500 ms pulse. The dura-
tion of each pulse train was 30 s, and the interval between 
pulse trains was 5  min. The amplitude of the pulse was 
initially set to 1 mA, after surgery to progressively reach 
5  mA 1  week later. This value was maintained until the 
end of the experiment.
c. 18FDG image acquisition and analysis
Brain metabolism was quantified using PET imaging 
after 18Fluoro-deoxyglucose injection. PET images were 
acquired on an ECAT EXACT HR CTI/Siemens scan-
ner while the animal was anesthetized using isoflurane 
according to a previously published procedure [6]. Axial 
projections were corrected for dead time, decay and pho-
ton attenuation. Cerebral metabolic rate for glucose utili-
zation (CMRglu) coded images were obtained using the 
dynamic PET images series and the arterial input func-
tion using Pmod 3.8 (PMod, Switzerland) adapted to the 
porcine brain. A value of 0.45 was selected for lump con-
stant of the porcine brain [25] and 1.05 g/ml for the den-
sity of the brain tissue. Glycemia during the PET imaging 
was obtained from the arterial samples and measured 
using the glucose oxidase method on a rapid analyzer 
(Analox GM9 Analyzer; Analox Instruments, London, 
UK). The CMRglu coded image set obtained using FDG 
compartment modeling was used afterwards for the 
quantitative analyses.
Statistical analyses of glucose brain uptake images 
were performed using SPM12 with significance level 
set at P < 0.001 FDR corrected to exclude random brain 
activation [26]. Brain templates used for registration 
procedure were those described earlier [6] and were 
within the same tridimensional reference as our pig 
brain atlas [22]. Metabolic connectivity analysis was 
also performed using the CMRglu coded image set. 
Network components were obtained using NetPET V1 
(L. Moro, M. Veronese and M. Arcolin) according to 
Rubinov and Sporns [27, 28]. Brain networks (nodes 
and edges) were visualized using BrainNet Viewer [29] 
and the circularGraph Matlab routine. Nodes loca-
tions were obtained from the barycenter of volumes of 
interest describing the major brain structures obtained 
using the pig brain atlas (see Additional file 1: Table S1). 
Weight based thresholding for edges was used for sta-
tistical analysis together with the corresponding prob-
ability matrix [30].
d. 123I‑Ioflupane image acquisition and analysis
Dopamine and serotonin binding potential was quanti-
fied using dynamic SPECT imaging after 123I-ioflupane 
injection (180  MBq, DatScan, GE). Brain SPECT was 
achieved with a double head gamma camera (Millenium 
VG, GE) in isoflurane-anesthetized animals. Immediately 
after the intravenous administration of 123I-ioflupane, 
180-degree acquisitions were performed (3° Step, 45  s 
per frame, 128*128 pixels per frame) sequentially during 
about 6 h resulting in eight projection series used after-
wards to reconstruct a dynamic (4D) brain sequence. 
The corresponding projections were reconstructed using 
OSEM algorithm with NiftyRec/Matlab software and 
filtered afterward with a non-local means filter. Co-reg-
istered CT scan brain images (HiSpeed CT, GE) trans-
formed as attenuation maps for the 123Iodine photopeak 
were integrated into the NiftyRec projector to remove 
attenuation. Scatter compensation was also achieved 
using the Jaszczak subtraction method [31].
Dopamine transporter and SERT binding potentials 
(unitless) were obtained from 4D SPECT images using 
Ichise Multi-linear Reference Tissue Model [32] imple-
mented in PXMOD software with reference region being 
the cerebellum crus [33]. DAT and SERT areas were 
defined from the volumes of interest extracted using the 
pig brain atlas. The DAT rich areas embraced the Puta-
men and the Caudate nucleus whereas the SERT rich 
areas included the Pons and the MidBrain. Left and right 
structures were merged into a single volume for DAT and 
SERT rich volume of interest (VOI). The rationale for the 
classification of the volumes into DAT and SERT rich 
areas followed the work of Peremans [33] and Roselli [34] 
adapted to the anatomical particularities of the porcine 
brain. Differences between binding potential in sham and 
stimulated group were analyzed using T-test with P < 0.05 
as threshold for significance.
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e. Ancillary measurements
Phenotypic characterization of the obesity status was 
performed during the last anesthesia procedure per-
formed also used for imaging. It includes the evaluation 
of the whole-body metabolism by indirect calorimetry 
and the analysis of fat tissue mass using CT scan. Energy 
expenditure and carbohydrate oxidation rate were meas-
ured by indirect calorimetry. A breath to breath meta-
bolic analyzer (Quark RMR Cosmed) was attached to a 
non-rebreathing ventilator (Siemens SAL 900) to meas-
ure the difference between inspired and expired VO2 and 
VCO2. The energy expenditure and carbohydrate oxida-
tion rate were determined, as described previously [6]. 
Fat mass repartition and lean mass were quantified by 
semi-automatic segmentation (Osirix 8.0) of CT-based 
images of the abdomen obtained at the levels of L1 and 
L3 (HighSpeed CT, GE) [35].
f. Non‑image statistical analyses
Non-image data are presented as mean ± SE and com-
pared by T-tests using Prism 7 (GraphPad, USA). 
Time-dependent analysis were corrected for multi-
ple comparisons using the Sidak test. Differences were 
regarded as statistically significant if P < 0.05.
Results
Adverse events associated either to the implantation or 
the stimulation were not observed during the course of 
the experiment.
a. Effect of abdominal bilateral VNS on body weight 
and metabolic balance
Electrode impedance was 834 ± 130 Ohms immedi-
ately after implantation and steadily increased up to 
1185 ± 182 Ohms during the first 4  weeks after sur-
gery. There was no difference between the impedances 
recorded on the dorsal vs ventral electrodes. Similarly, 
the changes in impedance were not significantly different 
between the sham and the stimulated group (P < 0.05).
All animals gained weight after surgery irrespective of 
the experimental group but it was less for stimulated than 
for sham group. The difference was significant 45  days 
after surgery (3.5 ± 0.39  kg vs. 4.6 ± 0.17  kg, P < 0.01 for 
stimulation vs. sham group) and continue to be so until 
the end of the experiment (3.7 ± 0.71 kg vs. 6.0 ± 0.30 kg, 
P < 0.01 for stimulation vs. sham group at 60 days). Diet 
intake, averaged for the experimental period, was about 
halved in stimulated versus sham group (473 ± 24.6 g/day 
vs. 810 ± 22.5 g/day, P < 0.01). Together with an increased 
in resting energy expenditure (2120 ± 127.4  kcal/day 
vs. 1305 ± 103.0  kcal/day, P < 0.01) observed in stimu-
lated versus sham group, the daily energy deficit was 
216 ± 21.3 kcal in the stimulated group. Fat deposit was 
decreased in stimulated group as a consequence of a 
decreased in visceral fat (Fig.  1). Subcutaneous fat was 
unchanged between groups (P > 0.05).
b. Changes in brain glucose metabolism
Statistical parameter mapping performed on quantitative 
CMRglu images showed that brain glucose uptake was 
increased in the stimulated group but for a limited num-
ber of brain areas only. They included the periaqueducal 
grey, the thalamic and hypothalamic areas and part of the 
amygdala and the insular cortex (Table 1, Fig. 2). Increas-
ing P values at 0.01 resulted in extended activation of the 
periaqueducal grey and additional activations of the infe-
rior temporal gyrus, the prepyriform area and the striate 
cortex (T = 3.307).
Correlation analysis showed that metabolic connectiv-
ity was significantly enhanced in stimulated versus sham 
group as indicated by significantly different matrices of 
pair-wise correlations. Several networks were identified 
in the stimulated group (Fig.  3). The connectivity with 
the hippocampus and the amygdala formed a strong 
functional network with the anterior thalamic area. Simi-
larly, we identified a significant connectivity between the 
cingulate structures, the postcentral gyrus, the insular 
cortex and the mid-brain. There was little connectivity 
involving the striatum either in the sham or in the stimu-
lated group.
c. Changes in DAT and SERT binding potential
The binding potential of DAT (in DAT-rich areas) was 
significantly decreased in stimulated versus sham group 
whereas that of SERT (in SERT-rich areas) increased 
(Fig.  4). DAT binding decreased by 26% whereas SERT 
binding about doubled in stimulated group compared to 
the sham. There was very little binding (lower than 0.2) 
outside DAT and SERT rich areas and this was not differ-
ent between groups (P = 0.120).
Discussion
Our study demonstrates that bilateral abdominal vagal 
stimulation generated a unique brain response associated 
with reduced body-weight gain, diminished daily food 
intake, lowered visceral fat and increased resting energy 
expenditure in obese non-diabetic animals. This central 
response is characterized by an extensive increase in 
brain connectivity whereas statistical parameter mapping 
identified only limited changes in CMRglu. The molecu-
lar mechanism responsible for these patterns involved a 
doubling in SERT binding at the Mid-brain/Pons whereas 
DAT binding within the striatum was significantly 
reduced.
Bilateral vagal stimulation performed at the abdomi-
nal level reduced body-weight gain in obese animals. 
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Fig. 1 Evolution in body weight gain for sham and abdominal vagal stimulated groups (top left panel). Note that body weight relative to the 
pre‑operative one was significantly reduced in the stimulated group after 45 days of continuous stimulation. This reduction was a consequence of 
both a diminished daily food intake (top right panel) and an increased resting energy expenditure (bottom right panel). The decreased body weight 
in the stimulated group was representative of a reduced visceral fat (bottom left panel)
Table 1 Statistical parameter mapping analysis of  activation patterns (local maxima) obtained from  18FDG PET scan 
in stimulated animals compared to sham
The analysis was performed with the cluster size of 100 voxels. Values of P were presented using FDR correction. Tentative anatomic localization is given based on 
interpretation of the projection of the activation pattern on the pig brain anatomic atlas published by our group [22]
Coordinate of local maximum (x, y, z 
in mm)
Pcorrected (voxel level) T‑value (voxel level) Tentative anatomic localization
2, − 11, − 8 0.001 7.46 Periaqueducal grey
− 4, − 6, − 6 0.001 6.96 Periaqueducal grey
6, 9, − 2 0.001 6.32 Ventral anterior thalamus R
− 0, 9, − 9 0.003 5.46 Medial hypothalamic area
− 18, 7, − 4 0.002 6.06 Amygdala L
− 10, 28, − 6 0.004 4.88 Insula L
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This was confirmed in experimental conditions limit-
ing false positive i.e., (i) large number of animals, (ii) 
extended duration of stimulation, (iii) procedure that 
avoided tissue damage and improved surgical recov-
ery. The weight reduction was quantitatively small and 
occured several weeks only after the onset of continu-
ous stimulation. However, compared to marketed drug 
therapies for chronic weight management, vagal stimu-
lation was performing similarly than the best pharma-
cotherapy available [36]. Indeed, the marketed drugs 
achieved 3% to 9% weight loss, relative to placebo, after 
1  year. This weight loss translates into about 32  g per 
day while in our experiment, the animals loosed 38.7 g 
per day compared to sham. Furthermore, the energy 
deficit observed in stimulated animals was within the 
range of the required energy deficit per unit weight 
loss in patients. Indeed, one of the most pervasive 
weight loss rules states that a cumulative energy defi-
cit of 3500 kcal is necessary to lose 1 lb of body weight 
[37]. Here, at 60  days post stimulation, the animals 
have a daily energy deficit of 216 kcal, and the cumula-
tive energy deficit suggests that one kg will be lost in 
36 days. These crude calculations did not allow for the 
ratio between lean and fat mass [38] that acted as an 
adjustment variable for the equivalence between weight 
loss and energy deficit. Nevertheless, the convergence 
of these figures suggests that both feeding behavior 
and energy expenditure are keys components to under-
stand the origin of weight loss observed during vagal 
stimulation.
8
2
8
2
Ventral anterior thalamus
Periaqueducal grey
P A
AP
RL AP L R
AP
Fig. 2 Statistical parameter mapping of 18FDG uptake (CMRglu) in sham and stimulated group. SPM analysis was performed using pixel‑wise 
modeled quantitative PET images. Statistical differences were analyzed using T‑test in SPM12, P < 0.001 FDR and cluster level corrected. The analysis 
was performed with a cluster size of 100 voxels each of the cluster representing 1 mm3. Note the activation in the thalamic and periaqueducal grey 
areas. Top left—brain glass with activation in shade of grey. Top right—thresholded activation (in color scale) depicting the ventral anterior thalamic 
activation. Bottom left—3D representation of the activation matrix. Shade of red indicates activation. Bottom right—thresholded activation (in color 
scale) with the image centered on the periaqueducal grey
Page 7 of 11Malbert et al. J Transl Med           (2019) 17:78 
Numerous studies have investigated the effect of unilat-
eral cervical VNS either in healthy animals or in epileptic 
and depressive patients [39]. While several confounding 
factors exist in humans’ studies including the analytic 
methods and the outcome of the disease, the involve-
ment of thalamic, limbic and prefrontal structures were 
the most consistent findings [40, 41] especially using 
fMRI imaging. These activations differed from the c-fos 
or ∆FosB data obtained in healthy rats [42] for which, 
aside from bulbar activation, frontal, cingulate and amyg-
dala cortices together with part of the striatal system 
were activated during chronic application of VNS. Sur-
prisingly, bulbar activation, the main entrance for vagal 
afferents, was only recently identified using noninvasive 
imaging either in animals with pulson type vagal stimu-
lation [7] or in humans with transcutaneous VNS [43]. 
Sometimes, the reported activity highlight activations in 
different regions or even opposite responses in the same 
regions [44]. It is extremely likely that most of these dif-
ferences were related to the non-quantitative analysis 
[45]. The methodological challenge for truly quantitative 
PET imaging explains probably the oversimplification 
in imaging procedures. Here, using quantitative CMR-
glu measurement, we found that most regions activated 
in abdominal VNS group were located within the tha-
lamic area, the periaqueducal grey and to a lesser extend 
within the amygdala and the insular cortex. Therefore, 
our data demonstrated a robust activation of these struc-
tures unlike the mixture of activations and deactivations 
on frontal, limbic, thalamic and mid-brain structures 
reported during unilateral cervical vagal stimulation.
Sham Stimulated
A
P
A P AP
Fig. 3 Metabolic connectivity analysis in the sham and stimulated groups. A. The figures showed the results of connectivity analysis performed 
with NetPET software using CMRglu coded voxel‑vised images. Top panels—surface renderings of the brain overlaid with network connections. 
Nodes and edges were coded using BrainNet viewer and edges were thresholded for P < 0.001. Only nodes with attached edges were represented. 
Bottom panels—Correlograms representing the correlation weighted matrices thresholded at P < 0.001. Nodes’ abbreviations are expended in the 
Additional file 1: Table S1. Note the increased metabolic connectivity in stimulated compared to sham group
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Network analysis on quantitative CMRglu images iden-
tified an increase in the metabolic connectivity for sev-
eral brain structures well outside those identified by SPM 
analysis. This change was reminiscent that observed by. 
Cao et  al. [12] who found that acute left cervical VNS 
reorganized the functional connectivity of the limbic sys-
tem. However, unlike Cao et al. [12] brain-wide responses 
were not identified with chronic aVNS. The involvement 
of the amygdala observed both in connectivity analysis 
and SPM measurements deserves some attention since 
it has not been identified earlier with aVNS. Memory 
storage processes and neuronal plasticity in the hip-
pocampus have been already observed in rat during vagal 
stimulation at the cervical level [46]. Furthermore, word-
recognition memory was improved by chronic cervical 
vagal stimulation in humans [47]. All these agreed with 
a vagally induced increased metabolism of these brain 
region (e.g. increased CMRglu).
Serotonin transporter binding potential doubled 
in the mid-brain and pontine areas for the stimulated 
group. An increased release of serotonin has been 
already demonstrated in some areas of the mesenceph-
alon during cervical VNS [48]. Since, there is a direct 
relationship between the synaptic release of seroto-
nin and SERT expression in rats [49], it is likely that 
the improvement of SERT binding potential reflects 
an increase of 5HT release as a consequence to aVNS. 
To what extent this phenomenon is beneficial for a 
reduction in food intake or is the consequence of the 
reduced body weight is debatable. An inverse relation-
ship between brain serotonin, food intake and body 
weight has been strongly established [50, 51]. Further-
more, a causal link between the central nervous system 
biogenic amine targets (namely 5-HT) and the energy 
expenditure has been established preclinically and 
clinically [52]. Therefore, it is logical that the increased 
binding potential of SERT observed in stimulated ani-
mals participates in the reduction in body weight 
together with the increased energy expenditure. The 
decreased SERT availability in the midbrain of obese 
0
5
0
5
Sham
Stimulated
DAT rich area
SERT rich area
*
0
1
2
3
4
Sham
Stimulated
*
Fig. 4 Left panels—examples of reconstructed normalized volumes obtained after the administration of 123I ioflupane in sham versus stimulated 
animals. The colors represented pixel‑wise modeled SPECT dynamic image series according to Ichise i.e., the binding potential overlaid on the MRI 
template of the pig brain atlas. Red VOIs corresponded to DAT‑rich areas whereas yellow VOIs represented SERT‑rich areas. Right panel—binding 
potential for DAT and SERT in sham versus stimulated groups obtained from region‑based analysis. *Indicates a significant difference at P < 0.001
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women [53] and vice versa the increase of SERT avail-
ability following the successful treatment of eating dis-
order in a subgroup of the same patients [54] confirm 
this hypothesis. Finally, the recent identification of a 
mid-brain circuit associated with serotonin release that 
control food intake in the rat [17] fits adequately within 
the overall picture of a mid-brain SERT mediated effect 
of aVNS.
Dopamine transporter binding potential was also 
decreased by one third in the striatum of aVNS ani-
mals. Unlike SERT, this reduced DAT binding poten-
tial translates probably into an enhanced dopamine 
concentration within the same brain structures dopa-
mine levels increased within the same structures in 
DAT knockout animals [51, 55]. Unsurprisingly, cervi-
cal VNS enhanced extracellular dopamine level in the 
prefrontal cortex and the striatum of healthy rats [48]. 
Furthermore, since pharmacologically increased mes-
olimbic dopamine activity obtained by selective inhibi-
tion of DAT was sufficient to suppress feeding [56], it is 
likely that the decrease DAT binding potential observed 
in the stimulated group was primarily causative for the 
reduction in food intake. Nevertheless, the negative 
correlation between body mass index and DAT1 gene 
expression that translated into inhibition of DAT bind-
ing in obese is somewhat contradictory with the previ-
ous observations. However, an absence of correlation 
was also reported by several authors who investigated 
exclusively non-diabetic (healthy) obese [57, 58].
Our study has several limitations due to the particu-
larities of the porcine experimental model. First, the 
obese insulino-dependent pig did not exhibit diabe-
tes unlike other experimental animals while fed with a 
high-fat high energy diet [59, 60]. Since it is believed 
that at least half of obese individuals were metaboli-
cally healthy, i.e., nondiabetic [61], this unique feature 
of the porcine model is somewhat positive as it mimics 
the human pathology. However, because in the obese 
individual, striatal DAT likely depends on the diabetic 
vs. nondiabetic status [58, 62], we cannot ascertain 
that the effect observed on DAT in our model is repre-
sentative of the human pathological condition. Second, 
Minuzzi et al. found that two others propane derivative 
labeled with 11C have low pharmacological specific-
ity for DAT in pigs [63]. It is questionable whether this 
also applies to 123I ioflupane but this might have some 
consequences on the distribution of SERT in SERT-rich 
areas. Nevertheless, unlike Minuzzi et al. [63], we used 
several methods that taken together produced quan-
titative DAT/SERT binding potential measurements: 
attenuation and diffusion corrections, Ichise multi-
linear reference tissue reconstruction with 4D data 
using extensive acquisition duration. Finally, using the 
aforementioned techniques, 123I ioflupane radioactiv-
ity concentrates in the striatum and in the mid-brain/
Pons. The amount of binding outside these structures is 
neglectable in line with the observations performed in 
other species and in humans [33].
Our study did not investigate different stimulation 
schemes because, despite their potential interest, dose–
response curves were almost impossible to build in our 
model. Indeed, the impact of VNS towards food intake 
took several weeks to be significant [3]. Recently, we 
were able to observe a significant alteration of the feeding 
behavior after 2  weeks but this was achieved on young 
animals with a complex stimulation scheme involving 
high frequency chopped current pulses [7]. Further-
more, no experimental data were available to evaluate 
an adequate washout period (if any) before changing 
one stimulation parameter. Finally, due to the intricacy 
of the numerous parameters constituting a stimulation 
scheme (pulse duration, pulse frequency, duration of the 
burst, interval between burst and stimulation current), 
evaluation of each component individually proved to be 
impracticable [5].
Conclusions
Abdominal bilateral chronic vagal stimulation, per-
formed in conditions close to a future clinical setting (i.e., 
laparoscopic vagal access, stimulation with implanted 
stimulator lasting several weeks), was able to effectively 
reduce food intake and body weight. This was associated 
with brain metabolism changes that differed significantly 
from those observed during cervical unilateral vagal 
stimulation. We identified an enhanced brain connectiv-
ity involving several areas such as the striatum, cingulate, 
insula, thalamus, amygdala, hippocampus and mid-brain. 
These changes occurred together with profound altera-
tions in DAT and SERT binding potentials. DAT bind-
ing potential was decreased in the striatum while SERT 
binding potential was doubled in the mid-brain. All of 
the above might be pivotal to explain the origin of the 
reduced food intake and diminished weight gain induced 
by aVNS. Furthermore, notwithstanding the application 
of aVNS for morbid obesity, these changes gave new ave-
nues for drug-based therapies targeted towards control of 
food intake in the obese.
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